NEIL2 and cancer: The levels of NEIL1 and NEIL2 mRNA expression in tumor tissue, compared with normal tissue, were significantly reduced in 6 of the 13 (46.2%) cancer types and 4 of the 13 (30.8%) cancer types, respectively (Supplementary Table S2, Supplementary Figure S3).